These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7265112)

  • 41. Fluorinated colchicinoids: antitubulin and cytotoxic properties.
    Ringel I; Jaffe D; Alerhand S; Boye O; Muzaffar A; Brossi A
    J Med Chem; 1991 Nov; 34(11):3334-8. PubMed ID: 1956052
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interaction of tubulin with single ring analogues of colchicine.
    Andreu JM; Timasheff SN
    Biochemistry; 1982 Feb; 21(3):534-43. PubMed ID: 7066305
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interaction of tubulin with bifunctional colchicine analogues: an equilibrium study.
    Andreu JM; Gorbunoff MJ; Lee JC; Timasheff SN
    Biochemistry; 1984 Apr; 23(8):1742-52. PubMed ID: 6722122
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 99mTc-labeling of colchicine using [99mTc(CO)3(H2O)3]+ and [99mTc triple bond N]2+ core for the preparation of potential tumor-targeting agents.
    Korde A; Satpati D; Mathur A; Mallia M; Banerjee S; Kothari K; Sarma HD; Choudhari P; Venkatesh M
    Bioorg Med Chem; 2006 Feb; 14(3):793-9. PubMed ID: 16289854
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects on tubulin polymerization and down-regulation of c-Myc, hTERT and VEGF genes by colchicine haloacetyl and haloaroyl derivatives.
    Marzo-Mas A; Falomir E; Murga J; Carda M; Marco JA
    Eur J Med Chem; 2018 Apr; 150():591-600. PubMed ID: 29550732
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aging of tubulin at neutral pH: stabilization by colchicine and its analogues.
    Prakash V; Timasheff SN
    Arch Biochem Biophys; 1992 May; 295(1):146-52. PubMed ID: 1575511
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A correlation between the effects of anti-mitotic drugs on microtubule assembly in vitro and the inhibition of axonal transport in noradrenergic neurones.
    Banks P; Till R
    J Physiol; 1975 Oct; 252(1):283-94. PubMed ID: 53281
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and biological evaluation of furanoallocolchicinoids.
    Voitovich YV; Shegravina ES; Sitnikov NS; Faerman VI; Fokin VV; Schmalz HG; Combes S; Allegro D; Barbier P; Beletskaya IP; Svirshchevskaya EV; Fedorov AY
    J Med Chem; 2015 Jan; 58(2):692-704. PubMed ID: 25496412
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Colchicine-binding protein of the liver. Its characterization and relation to microtubules.
    Patzelt C; Singh A; Marchand YL; Orci L; Jeanrenaud B
    J Cell Biol; 1975 Sep; 66(3):609-20. PubMed ID: 808552
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metabolic transformation of colchicine, IV[1]. On the interaction of colchicine and colchiceine with sulfhydryl compounds.
    Schnell E; Schönharting M; Siebert G
    Hoppe Seylers Z Physiol Chem; 1976 Apr; 357(4):567-71. PubMed ID: 964916
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mechanism of colchicine binding to tubulin. Tolerance of substituents in ring C' of biphenyl analogues.
    Andreu JM; Gorbunoff MJ; Medrano FJ; Rossi M; Timasheff SN
    Biochemistry; 1991 Apr; 30(15):3777-86. PubMed ID: 2015233
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Potential anticancer role of colchicine-based derivatives: an overview.
    Kumar A; Sharma PR; Mondhe DM
    Anticancer Drugs; 2017 Mar; 28(3):250-262. PubMed ID: 28030380
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of membrane lipid composition and microtubule structure on lectin interactions of mouse LM cells.
    Rittenhouse HG; Williams RE; Fox CF
    J Supramol Struct; 1974; 2(5-6):629-45. PubMed ID: 4477883
    [No Abstract]   [Full Text] [Related]  

  • 54. Docking study of ligands into the colchicine binding site of tubulin.
    Farce A; Loge C; Gallet S; Lebegue N; Carato P; Chavatte P; Berthelot P; Lesieur D
    J Enzyme Inhib Med Chem; 2004 Dec; 19(6):541-7. PubMed ID: 15662957
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis and biological evaluation of novel anticancer bivalent colchicine-tubulizine hybrids.
    Malysheva YB; Combes S; Allegro D; Peyrot V; Knochel P; Gavryushin AE; Fedorov AY
    Bioorg Med Chem; 2012 Jul; 20(14):4271-8. PubMed ID: 22739088
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The influence of certain colchicine derivatives on the growth characteristics of L cells.
    Spurná V; Santavý F; Lang BA
    Gen Physiol Biophys; 1985 Aug; 4(4):383-92. PubMed ID: 4029603
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biotherapeutic potential and mechanisms of action of colchicine.
    Dubey KK; Kumar P; Labrou NE; Shukla P
    Crit Rev Biotechnol; 2017 Dec; 37(8):1038-1047. PubMed ID: 28436240
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rapid rate of tubulin dissociation from microtubules in the mitotic spindle in vivo measured by blocking polymerization with colchicine.
    Salmon ED; McKeel M; Hays T
    J Cell Biol; 1984 Sep; 99(3):1066-75. PubMed ID: 6470037
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tubulin binding affinities of podophyllotoxin and colchicine analogues.
    Kelleher JK
    Mol Pharmacol; 1977 Mar; 13(2):232-41. PubMed ID: 854021
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of colchicine and its derivatives on the expression of selected isoforms of cytochrome P450 in primary cultures of human hepatocytes.
    Dvorák Z; Ulrichová J; Modrianský M; Maurel P
    Acta Univ Palacki Olomuc Fac Med; 2000; 143():47-50. PubMed ID: 11144118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.